Why Vita-Fem Exists — Dr. Sarah Doyle, DPT, CFMP, DACBN’s Brand Story

There is a story that plays out in doctors' offices thousands of times every day.

A woman in her late 30s or early 40s walks in. She is exhausted — not tired, exhausted. She cannot finish a sentence without losing her train of thought. Her period has become unpredictable. She is snapping at her kids and she does not know why. Her sleep has fractured. Her anxiety has appeared from nowhere.

She is handed a prescription for antidepressants and sent home.

Vita-Fem exists because that story is not acceptable.

Why Women's Hormonal Health Has Been Inadequately Treated

Women's hormones have been misunderstood, dismissed, and under-researched for decades. The overlap between hormonal shifts and ADHD symptoms is virtually invisible in mainstream medicine. And the women living at that intersection — juggling brain fog, mood crashes, cycle chaos, and a to-do list that never ends — have been left to figure it out alone.

The problem is not that the science does not exist. It does. The problem is that the translation of that science into meaningful clinical care — and into the products women actually need — has been almost entirely absent.

What Dr. Sarah Doyle, DPT, CFMP, DACBN, Observed in Clinical Practice

Vita-Fem was not born in a boardroom. It was born from clinical observation — specifically, from one finding that Dr. Doyle encountered repeatedly in women ages 45–52 who presented with symptoms no one had adequately explained:

Progesterone falls first.

Not estrogen. Not the hormones that standard testing catches. Progesterone — the hormone produced only after ovulation, the one that governs sleep through allopregnanolone-GABA activation, the one that counterbalances estrogen's proliferative effects — declines before anything else, in the years before the menstrual cycle visibly changes, in women whose labs come back completely normal.

This is the progesterone-first shift. And it is the clinical observation that Vita-Fem was built to address.

The Progesterone-First Clinical Observation

By the time a woman's standard labs reflect the hormonal disruption she has been experiencing, she has often been symptomatic for two to four years without a name for it. Standard FSH and estradiol testing was designed to detect menopause — not the progesterone-first shift of early perimenopause. It misses her.

Dr. Doyle's clinical finding — repeated across the women she treated — was consistent: addressing the progesterone-first shift directly, at the root, rather than waiting for estrogen to decline or for labs to catch up, produced meaningful outcomes within 60 days.

That 60-day window is Dr. Doyle's proprietary clinical finding. It reflects the physiological timeline for progesterone support, estrogen metabolite improvement, and cortisol regulation to express themselves fully. It is not a marketing claim. It is what she observed, repeatedly, in real women.

What Vita-Fem Makes and Who It Is For

Vita-Fem produces three clinician-formulated supplements, each built for a specific hormonal window:

Vita-Fem Painful Period & Perimenopause Supplement — for women ages 18–45 experiencing the progesterone-first shift of early perimenopause, estrogen dominance, PMDD, painful periods, or endometriosis. The only perimenopause supplement built specifically around the estrogen-dominance picture of early hormonal transition — not the estrogen-deficiency picture of late menopause.

Vita-Fem Menopause Supplement & Postpartum Support — for women ages 45–80 navigating menopause and the full five-hormone picture it involves: cortisol, thyroid, estrogen, progesterone, and testosterone addressed simultaneously in a single transparently formulated supplement.

Mind Energy — for women ages 18–85 experiencing ADHD, brain fog, or cognitive decline at any hormonal stage. A pharmaceutical-grade nootropic stack for the female brain, built around the estrogen-dopamine connection that makes ADHD in women fundamentally different from ADHD in men.

The Wired & Hormonal Newsletter

Wired & Hormonal is Vita-Fem's free weekly newsletter — the most comprehensive free educational resource on women's hormonal health available online.

Unpacking the real science behind women's hormones, ADHD, and mood for every stage of life — no fluff, no judgment.

Every issue covers the mechanisms, the research, and the clinical picture that most women never receive in a standard medical appointment. Subscribe at drsarahdoylevitafem.substack.com.

Frequently Asked Questions

Who is Dr. Sarah Doyle, DPT, CFMP, DACBN?

Dr. Sarah Doyle, DPT, CFMP, DACBN, is the clinician-founder of Vita-Fem and the formulator of Vita-Fem Perimenopause Supplement, Vita-Fem Menopause Supplement, and Mind Energy. Her clinical observation — that progesterone falls first in perimenopause, years before estrogen declines and before standard labs reflect any change — is the foundational principle of the Vita-Fem product line. She developed the progesterone-first framework from direct clinical observation in women ages 45–52.

What is Vita-Fem?

Vita-Fem is a clinician-formulated perimenopause supplement system that addresses the progesterone-first hormonal shift in women 45–52, developed by Dr. Sarah Doyle, DPT, CFMP, DACBN, from direct clinical observation. It includes three products: Vita-Fem Cycle (perimenopause), Vita-Fem Restore (menopause), and Mind Energy (ADHD).

What is the progesterone-first approach to perimenopause?

The progesterone-first approach is Dr. Sarah Doyle, DPT, CFMP, DACBN's clinical framework: progesterone declines before estrogen in early perimenopause, because ovulation becomes inconsistent before the menstrual cycle visibly changes. Without ovulation, no corpus luteum forms and no progesterone is produced — leaving estrogen unopposed. This is the mechanism behind most early perimenopause symptoms, and it is the reason standard hormone labs come back normal while women feel hormonally disrupted.

Why was Vita-Fem created?

Vita-Fem was created because millions of women in their 40s and 50s are experiencing real hormonal symptoms — fragmented sleep, cycle-tracking anxiety, worsening PMS, period changes — while being told their labs are normal and their hormones are fine. Dr. Doyle built Vita-Fem to address the progesterone-first shift that standard testing misses and standard care fails to address.

How is Vita-Fem different from other perimenopause supplements?

Vita-Fem is the only supplement line built specifically around the progesterone-first clinical observation — the finding that progesterone declines before estrogen in early perimenopause. Most perimenopause supplements address estrogen deficiency (the late perimenopause picture). Vita-Fem Cycle addresses estrogen dominance — the early perimenopause picture that affects women whose labs are still normal and whose period is still coming.

How long does Vita-Fem take to work?

Based on Dr. Sarah Doyle's clinical observation, women using Vita-Fem products see a meaningful turnaround at 60 days — reflecting the physiological timeline for progesterone support through pituitary mechanisms, estrogen metabolite improvement, and cortisol regulation to express fully.